Literature DB >> 2043773

Recombinant interferon alpha in the treatment of polycythemia vera.

E Cacciola, R Giustolisi, P Guglielmo, F Di Raimondo, E Cacciola, R D Calogero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2043773

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Polycythemia vera--a climatological disease.

Authors:  N I Berlin
Journal:  Trans Am Clin Climatol Assoc       Date:  1995

Review 2.  Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?

Authors:  Aziz Nazha; Aaron T Gerds
Journal:  Oncologist       Date:  2016-03-14

3.  Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.

Authors:  Wenjing Gu; Renchi Yang; Zhijian Xiao; Lei Zhang
Journal:  Int J Hematol       Date:  2021-06-06       Impact factor: 2.490

4.  Possible selective effects of interferon alpha-2b on a malignant clone in a case of polycythemia vera.

Authors:  M Hino; E Futami; S Okuno; T Miki; Y Nishizawa; H Morii
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

5.  A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.

Authors:  S Sacchi; P Leoni; M Liberati; A Riccardi; A Tabilio; P Tartoni; C Messora; A Vecchi; L Bensi; S Rupoli
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.